Julia Klermund
Freiburg, BW 79106, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation.
Journal: Molecular therapy. Advances
Published: December 12, 2025
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations.
Journal: Nature biotechnology
Published: April 30, 2024
Modulation of TCR stimulation and pifithrin-α improve the genomic safety profile of CRISPR-engineered human T cells.
Journal: Cell reports. Medicine
Published: February 05, 2024
On- and off-target effects of paired CRISPR-Cas nickase in primary human cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 30, 2023
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1.
Journal: EMBO molecular medicine
Published: June 28, 2023
Transient inhibition of 53BP1 increases the frequency of targeted integration in human hematopoietic stem and progenitor cells.
Journal: Nature communications
Published: February 23, 2023
Clinical genome editing to treat sickle cell disease-A brief update.
Journal: Frontiers in medicine
Published: October 09, 2022
Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 25, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026